Search for: "Merck KgaA" Results 21 - 40 of 69
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
27 Jan 2016, 6:07 pm
The AmeriKat passed out on all of herco-existence agreements...A mammoth decision from Mr Justice Norris plopped on the AmeriKat's desk last week in the long-running awaited trade mark co-existence saga of Merck KGaA v Merck Sharp & Dohme [2016] EWHC 49 (Pat). [read post]
3 Jan 2024, 12:08 am by Adeline Chong
Guest post by Professor Yeo Tiong Min, SC (honoris causa), Yong Pung How Chair Professor of Law, Yong Pung How School of Law, Singapore Management University Merck Sharp & Dohme Corp (formerly known as Merck & Co, Inc) v Merck KGaA (formerly known as E Merck) [2021] 1 SLR 1102, [2021] SGCA 14 (“Merck”), noted previously, is a landmark case in Singapore private international law, being a decision of a full bench of the Court of… [read post]
15 Jun 2017, 8:43 am by Lawrence B. Ebert
From GEN:MilliporeSigma, the life science business of Merck KGaA, said today it has been awarded its first patent for CRISPR technology—an Australian patent relating to the use of CRISPR in a genomic integration method for eukaryotic cells.(...)Patent Application No. 2013355214 was filed December 5, 2013, and accepted on May 22, according to an online search of the Australian Patent Office’s online database AusPat. [read post]
26 May 2021, 8:40 pm by Adeline Chong
Written by Professor Yeo Tiong Min, SC (honoris causa), Yong Pung How Chair Professor of Law, Yong Pung How School of Law, Singapore Management University In Merck Sharp & Dohme Corp v Merck KGaA [2021] SGCA 14, a full bench of the Singapore Court of Appeal addressed the limits of transnational issue estoppel in Singapore law, and flagged possible fundamental changes to the common law on the recognition and enforcement of foreign judgments in Singapore. [read post]
5 Oct 2012, 7:07 am by Lisa Salazar
Extrafolate®Merck Eprova, a Swiss subsidiary of Germany’s Merck KGaA, manufactures and sells Metafolin®, a synthesized form of L-methylfolate, a naturally occurring folate. [read post]
26 Aug 2010, 4:05 am by Lawrence B. Ebert
Meanwhile, Merck KGaA (“Merck”) funded research on angiogenesis by Dr. [read post]
27 Feb 2018, 12:24 pm by Lawrence B. Ebert
Merck KGaA, 496 F.3d 1334, 1345 (Fed. [read post]
28 Sep 2007, 8:51 am
Merck oHG, which is Merck KgAA's generic subsidiary. [read post]
2 Dec 2011, 8:34 am
Germany's Merck wants Facebook page back Germany's Merck KGaA has threatened legal action after it said it lost its Facebook page apparently to rival Merck & Co. in the U.S., though it has yet to identify defendants in the case. [read post]
30 Mar 2009, 5:30 am
Here’s $100 million that is definitely going to biotechnology:   Texas announced $50 million of funding for a National Center for Therapeutics Manufacturing, but can’t shake anti-stem cell legislators or a creationist curriculum, and Merck KGaA is starting a biotechnology venture capital fund that will invest ââ [read post]
8 Apr 2009, 11:47 am
There will be a phased voluntary withdrawal of psoriasis drug Raptiva from the U.S. market due to its link to a brain infection.Raptiva has recently been associated with an increased risk of progressive multifocal leukoencephalopathy (PML), a rare and usually fatal disease of the central nervous system.Authorities in Europe, where Raptiva is sold by Merck KGaA (MRCG.DE), recommended in February that the drug be suspended in light of the PML risk.The European Commission is expected… [read post]
1 Oct 2007, 8:51 am
Merck oHG, which is Merck KgAA's generic subsidiary. [read post]
2 Dec 2011, 8:34 am
Germany's Merck wants Facebook page back Germany's Merck KGaA has threatened legal action after it said it lost its Facebook page apparently to rival Merck & Co. in the U.S., though it has yet to identify defendants in the case. [read post]
8 Nov 2018, 3:04 am
For practitioners the message was that whilst there may be a grace period for adjustments post-Brexit, it may be wiser to take action now in order to avoid issues such as being unable to service clients, and the rush to meet EUIPO guides that will likely incur high costs.The Keynote: Key Trade Mark Cases of the Last 12 monthsBenet Brandreth QC (11 South Square) gave an enthusiastic review of some of the most interesting Trade Mark cases in the last 12 months; such as Cartier v B Sky B;… [read post]